entertainment -WSS

entertainment

author：fashion 2025-09-28 12:10:14 - browse：59987

parts of a dna helix fades while a segment stays solid — Adobe

Flagship Pioneering, the venture capital firm behind Moderna, on Tuesday unveiled a new biotech called Quotient Therapeutics that will have offices in Massachusetts and the United Kingdom.

Quotient, which was founded last year and had operated in stealth mode, wants to develop drugs that target illnesses caused by genetic changes that occur as people age. Those conditions include immune diseases, cancers, neurodegenerative illnesses, and cardiometabolic disorders, such as heart attacks, strokes and diabetes.

With an initial of $50 million from the venture firm Flagship Pioneering, Quotient will be located in Cambridge, Mass., and Cambridge, England. Most of the academic co-founders work in the UK city. Quotient is the first Flagship-backed biotech that will be based in both countries.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Teacher posts viral 'school supply rant' with advice for parents

focus

WSS

Judge orders hearing on Trump's motion to disqualify Fulton County DA

Fla. should 'correct' controversial slavery curriculum: Republican Rep. Byron Donalds

This gene therapy has record $4.25 million price. It's saved children.

Adam's Take: Intra

Russian and Belarusian players banned from a women's tennis tournament in Prague

Snowpack in the West is melting rapidly. Where will all that extra water go?

leisure time

entertainment

focus

Malaria cases in Florida and Texas: Here’s what you need to know

What AstraZeneca

United colonoscopy coverage change 'may cost lives,' doctors say

With Wegovy coverage, Medicare patients may face high costs

ChatGPT in medicine: STAT answers readers' burning questions

American TikTok star stuck in Dubai for months following rental car altercation

The cancer drug shortage isn’t new — and neither are the solutions

Cancer, immunology, HIV research ensnared in fetal tissue politics

Drug repurposing or repositioning? The language matters

CRISPR technology availability, affordability needs to be expanded

hotspot

Cancer, immunology, HIV research ensnared in fetal tissue politics

Diabetes management: Digital health tools fall short, study says

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

U.K. officials, researchers try to ease path for bespoke genetic treatments

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

Adidas to release second batch of Yeezy sneakers after breakup with Ye

focus

explore

entertainment

knowledge